Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymph node retrieval rates in melanoma: a quality assessment parameter</title><author><name sortKey="Berger Richardson, D" sort="Berger Richardson, D" uniqKey="Berger Richardson D" first="D." last="Berger-Richardson">D. Berger-Richardson</name><affiliation><nlm:aff id="af1-conc-24-e323">Division of General Surgery, Department of Surgery, University of Toronto, Toronto;</nlm:aff></affiliation></author><author><name sortKey="Cordeiro, E" sort="Cordeiro, E" uniqKey="Cordeiro E" first="E." last="Cordeiro">E. Cordeiro</name><affiliation><nlm:aff wicri:cut="; and" id="af2-conc-24-e323">Division of General Surgery, Department of Surgery, University of Ottawa, Ottawa</nlm:aff></affiliation></author><author><name sortKey="Ernjakovic, M" sort="Ernjakovic, M" uniqKey="Ernjakovic M" first="M." last="Ernjakovic">M. Ernjakovic</name><affiliation><nlm:aff id="af1-conc-24-e323">Division of General Surgery, Department of Surgery, University of Toronto, Toronto;</nlm:aff></affiliation></author><author><name sortKey="Easson, A M" sort="Easson, A M" uniqKey="Easson A" first="A. M." last="Easson">A. M. Easson</name><affiliation><nlm:aff id="af1-conc-24-e323">Division of General Surgery, Department of Surgery, University of Toronto, Toronto;</nlm:aff></affiliation><affiliation><nlm:aff id="af3-conc-24-e323">Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON.</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">28874902</idno><idno type="pmc">5576471</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576471</idno><idno type="RBID">PMC:5576471</idno><idno type="doi">10.3747/co.24.3593</idno><date when="2017">2017</date><idno type="wicri:Area/Pmc/Corpus">001E63</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001E63</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Lymph node retrieval rates in melanoma: a quality assessment parameter</title><author><name sortKey="Berger Richardson, D" sort="Berger Richardson, D" uniqKey="Berger Richardson D" first="D." last="Berger-Richardson">D. Berger-Richardson</name><affiliation><nlm:aff id="af1-conc-24-e323">Division of General Surgery, Department of Surgery, University of Toronto, Toronto;</nlm:aff></affiliation></author><author><name sortKey="Cordeiro, E" sort="Cordeiro, E" uniqKey="Cordeiro E" first="E." last="Cordeiro">E. Cordeiro</name><affiliation><nlm:aff wicri:cut="; and" id="af2-conc-24-e323">Division of General Surgery, Department of Surgery, University of Ottawa, Ottawa</nlm:aff></affiliation></author><author><name sortKey="Ernjakovic, M" sort="Ernjakovic, M" uniqKey="Ernjakovic M" first="M." last="Ernjakovic">M. Ernjakovic</name><affiliation><nlm:aff id="af1-conc-24-e323">Division of General Surgery, Department of Surgery, University of Toronto, Toronto;</nlm:aff></affiliation></author><author><name sortKey="Easson, A M" sort="Easson, A M" uniqKey="Easson A" first="A. M." last="Easson">A. M. Easson</name><affiliation><nlm:aff id="af1-conc-24-e323">Division of General Surgery, Department of Surgery, University of Toronto, Toronto;</nlm:aff></affiliation><affiliation><nlm:aff id="af3-conc-24-e323">Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON.</nlm:aff></affiliation></author></analytic><series><title level="j">Current Oncology</title><idno type="ISSN">1198-0052</idno><idno type="eISSN">1718-7729</idno><imprint><date when="2017">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Introduction</title><p>Regional lymph node dissection (<sc>rlnd</sc>) for melanoma with nodal metastasis is a specialized procedure that is associated with improved disease-specific survival in selected patients. Furthermore, there is evidence that a higher lymph node retrieval rate (<sc>lnrr</sc>) is associated with improved local control. Currently, no consensus has been reached on the definition of an adequate <sc>lnrr</sc>. A minimum <sc>lnrr</sc> has been proposed as a quality assessment parameter that has to be validated.</p></sec><sec><title>Methods</title><p>We conducted a retrospective cohort analysis at the Princess Margaret Cancer Centre (University Health Network, Toronto, ON). The <sc>lnrr</sc>s for all patients who underwent <sc>rlnd</sc> for malignant cutaneous melanoma during 2000–2010 were recorded. Indications for <sc>rlnd</sc> were a positive sentinel lymph node biopsy or clinical lymphadenopathy (palpable or radiologically detected).</p></sec><sec><title>Results</title><p>Of the 207 identified <sc>rlnd</sc>s, 146 (70.5%) were subsequent to a positive sentinel lymph node biopsy, and 61 (29.5%) were performed for clinical lymphadenopathy. The median <sc>lnrr</sc> was 24 nodes (range: 9–47 nodes; 10th percentile: 14 nodes) for axillary <sc>rlnd</sc>, 12 nodes (range: 5–30 nodes; 10th percentile: 8 nodes) for inguinal <sc>rlnd</sc>, and 16 nodes (range: 10–21 nodes; 10th percentile: 11 nodes) for ilioinguinal <sc>rlnd</sc>. The results were similar when comparing patients with positive sentinel lymph nodes and those with clinical lymphadenopathy, and the same surgical techniques were used in both groups.</p></sec><sec><title>Conclusions</title><p>The <sc>lnrr</sc>s at our institution are similar to rates reported at other tertiary-care melanoma centres. A minimum acceptable <sc>lnrr</sc> can be considered a quality assessment parameter in the surgical management of melanoma with nodal metastasis.</p></sec></div></front></TEI><pmc article-type="brief-report"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Curr Oncol</journal-id><journal-id journal-id-type="iso-abbrev">Curr Oncol</journal-id><journal-id journal-id-type="publisher-id">CO</journal-id><journal-title-group><journal-title>Current Oncology</journal-title></journal-title-group><issn pub-type="ppub">1198-0052</issn><issn pub-type="epub">1718-7729</issn><publisher><publisher-name>Multimed Inc.</publisher-name><publisher-loc>66 Martin St. Milton, ON, Canada L9T 2R2</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28874902</article-id><article-id pub-id-type="pmc">5576471</article-id><article-id pub-id-type="doi">10.3747/co.24.3593</article-id><article-id pub-id-type="publisher-id">conc-24-e323</article-id><article-categories><subj-group subj-group-type="heading"><subject>Short Communication</subject></subj-group></article-categories><title-group><article-title>Lymph node retrieval rates in melanoma: a quality assessment parameter</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Berger-Richardson</surname><given-names>D.</given-names></name><degrees>MD CM MSc</degrees><xref ref-type="aff" rid="af1-conc-24-e323"><sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cordeiro</surname><given-names>E.</given-names></name><degrees>MD MSc</degrees><xref ref-type="aff" rid="af2-conc-24-e323"><sup>†</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ernjakovic</surname><given-names>M.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="af1-conc-24-e323"><sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Easson</surname><given-names>A.M.</given-names></name><degrees>MD MSc</degrees><xref ref-type="aff" rid="af1-conc-24-e323"><sup>*</sup></xref><xref ref-type="aff" rid="af3-conc-24-e323"><sup>‡</sup></xref><xref ref-type="corresp" rid="c1-conc-24-e323"></xref></contrib><aff id="af1-conc-24-e323"><label>*</label>Division of General Surgery, Department of Surgery, University of Toronto, Toronto;</aff><aff id="af2-conc-24-e323"><label>†</label>Division of General Surgery, Department of Surgery, University of Ottawa, Ottawa; and</aff><aff id="af3-conc-24-e323"><label>‡</label>Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON.</aff></contrib-group><author-notes><corresp id="c1-conc-24-e323">Correspondence to: Alexandra M. Easson, Princess Margaret Hospital, Room 3-130, 610 University Avenue, Toronto, Ontario M5T 2M9. E-mail: <email>Alexandra.easson@uhn.ca</email></corresp></author-notes><pub-date pub-type="ppub"><month>8</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>31</day><month>8</month><year>2017</year></pub-date><volume>24</volume><issue>4</issue><fpage>e323</fpage><lpage>e327</lpage><permissions><copyright-statement>2017 Multimed Inc.</copyright-statement><copyright-year>2017</copyright-year></permissions><abstract><sec><title>Introduction</title><p>Regional lymph node dissection (<sc>rlnd</sc>) for melanoma with nodal metastasis is a specialized procedure that is associated with improved disease-specific survival in selected patients. Furthermore, there is evidence that a higher lymph node retrieval rate (<sc>lnrr</sc>) is associated with improved local control. Currently, no consensus has been reached on the definition of an adequate <sc>lnrr</sc>. A minimum <sc>lnrr</sc> has been proposed as a quality assessment parameter that has to be validated.</p></sec><sec><title>Methods</title><p>We conducted a retrospective cohort analysis at the Princess Margaret Cancer Centre (University Health Network, Toronto, ON). The <sc>lnrr</sc>s for all patients who underwent <sc>rlnd</sc> for malignant cutaneous melanoma during 2000–2010 were recorded. Indications for <sc>rlnd</sc> were a positive sentinel lymph node biopsy or clinical lymphadenopathy (palpable or radiologically detected).</p></sec><sec><title>Results</title><p>Of the 207 identified <sc>rlnd</sc>s, 146 (70.5%) were subsequent to a positive sentinel lymph node biopsy, and 61 (29.5%) were performed for clinical lymphadenopathy. The median <sc>lnrr</sc> was 24 nodes (range: 9–47 nodes; 10th percentile: 14 nodes) for axillary <sc>rlnd</sc>, 12 nodes (range: 5–30 nodes; 10th percentile: 8 nodes) for inguinal <sc>rlnd</sc>, and 16 nodes (range: 10–21 nodes; 10th percentile: 11 nodes) for ilioinguinal <sc>rlnd</sc>. The results were similar when comparing patients with positive sentinel lymph nodes and those with clinical lymphadenopathy, and the same surgical techniques were used in both groups.</p></sec><sec><title>Conclusions</title><p>The <sc>lnrr</sc>s at our institution are similar to rates reported at other tertiary-care melanoma centres. A minimum acceptable <sc>lnrr</sc> can be considered a quality assessment parameter in the surgical management of melanoma with nodal metastasis.</p></sec></abstract><kwd-group><kwd>Melanoma</kwd><kwd>lymph node retrieval rates</kwd><kwd>quality assessment</kwd></kwd-group></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E639 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 001E639 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.31. |  |